AMERIPRISE FINANCIAL INC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$910,029
+46.3%
34,510
-4.5%
0.00%
Q2 2023$621,866
-0.3%
36,155
-3.9%
0.00%
Q1 2023$623,740
+34.7%
37,620
-38.0%
0.00%
Q4 2022$463,000
-24.0%
60,717
-0.9%
0.00%
Q3 2022$609,000
+250.0%
61,247
+219.1%
0.00%
Q2 2022$174,000
-74.2%
19,195
-52.5%
0.00%
Q4 2021$674,000
-65.6%
40,372
-3.4%
0.00%
-100.0%
Q3 2021$1,960,000
-16.5%
41,812
+8.5%
0.00%0.0%
Q2 2021$2,348,000
+8.3%
38,519
+9.4%
0.00%0.0%
Q1 2021$2,169,000
-28.4%
35,211
-17.3%
0.00%0.0%
Q4 2020$3,030,000
+82.6%
42,602
-3.7%
0.00%0.0%
Q3 2020$1,659,000
+8.7%
44,239
-5.5%
0.00%0.0%
Q2 2020$1,526,000
-10.0%
46,802
-20.0%
0.00%0.0%
Q1 2020$1,696,000
+66.9%
58,492
+101.9%
0.00%
Q4 2019$1,016,000
+71.9%
28,973
+5.2%
0.00%
Q3 2019$591,000
-12.7%
27,544
+9.7%
0.00%
Q2 2019$677,00025,1150.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders